DR. MAKARY, DR OZ: People talk about lowering healthcare costs, but the Trump administration is doing it
PositiveU.S News

The FDA has announced significant reforms aimed at streamlining the approval process for biosimilars, which could lead to substantial savings for Americans on prescription drug costs. By eliminating unnecessary clinical trial requirements, these changes are expected to make medications more accessible and affordable, reflecting a proactive approach by the Trump administration to tackle healthcare expenses.
— Curated by the World Pulse Now AI Editorial System











